enGene Holdings Inc.
ENGN · NASDAQ
10/31/2024 | 10/31/2023 | 10/31/2022 | 10/31/2021 | |
|---|---|---|---|---|
| Market Cap | $395 | $471 | $316 | $316 |
| - Cash | $173 | $82 | $20 | $11 |
| + Debt | $25 | $10 | $32 | $4 |
| Enterprise Value | $247 | $399 | $328 | $309 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | -$0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$52 | -$95 | $0 | $0 |
| % Margin | – | – | – | – |
| Net Income | -$55 | -$100 | $0 | -$23 |
| % Margin | – | – | – | – |
| EPS Diluted | -1.46 | -4.24 | 0.002 | -0.014 |
| % Growth | 65.6% | -223,257.9% | 113.3% | – |
| Operating Cash Flow | -$48 | -$25 | -$18 | -$16 |
| Capital Expenditures | -$1 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$49 | -$25 | -$18 | -$16 |